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Abstract 
Purpose: To investigate the anti-neuroinflammatory properties of Carum carvi Linn. (CCE, 
Umbelliferae) aqueous extract in stimulated BV-2 microglial cells and explore its underlying 
mechanisms.  
Methods: Cell viability assessment was performed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyl-
tetrazolium bromide (MTT) assay. Lipopolysaccharide (LPS) was used to activate BV-2 microglia. Nitric 
oxide (NO) levels were measured using Griess assay. Inducible NO synthase (iNOS) and 
cyclooxygenase (COX) levels were evaluated by Western blot analysis. Interleukin-6 (IL-6) and tumor 
necrosis factor-alpha (TNF-α) production were evaluated by enzyme-linked immunosorbent assay 
(ELISA).  
Results: CCE alone did not exhibit any signs of cytotoxicity to BV-2 cells up to 200 µg/ml concentration. 
The LPS-activated excessive release of NO in BV-2 cells was significantly inhibited by CCE (p < 0.001 
at 100 μg/mL). CCE also inhibited the production of inflammatory mediators such as iNOS, COX-2, IL-6 
and TNF-α (p < 0.05, p < 0.01 and p < 0.001 at 25, 50 and 100 μg/mL, respectively). Further 
mechanistic study revealed that CCE acts by regulation of nuclear factor kappa-B (NF-κB) signaling 
pathway in LPS-stimulated BV-2 microglial cells.  
Conclusion: The results reveal that CCE exhibited its anti-neuroinflammatory effects via regulation of 
NF-κB signaling. This can be developed as a potential therapeutic target in ameliorating microglia-
mediated neuroinflammation. 
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Carum carvi Linn from the family Umbelliferae is 
a globally distributed spice with a long history as 
a traditional medicinal plant [1]. Traditionally, the 
dried ripe fruits and leaves of the plant are used 
in folk medicine especially in the treatment of 
digestive disorders and as a vegetable in the 
preparation of soups, salads and sauces [2]. 
Experimental studies have revealed several 
benefits of C. carvi such as anti-dyspeptic, anti-
spasmodic, anti-ulcerogenic, anti-tumor, anti-
oxidant, anti-hyperglycemic, anti-hyperlipidemic 
and anti-inflammatory properties [3, 4]. Earlier 
reports from our group demonstrated that the 
aqueous extract of C. carvi fruit exhibited strong 
anti-oxidant, adaptogenic and memory 
enhancing effects in in vitro and in vivo 
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experimental models [5, 6]. However, till date the 
effect of C. carvi on microglia-mediated 
neuroinflammation was not elucidated.   
 
Microglia cells are ubiquitously distributed 
immune cells in the central nervous system 
(CNS) acting as first-line defense in neuronal 
injury [7]. Several factors disrupt the internal 
environment of the brain and trigger microglia 
activation. Once activated, microglia undergoes 
morphological changes simultaneously releasing 
a number of pro-inflammatory cytokines such as 
tumor necrosis factor α (TNF-α), interleukin (IL)-
1β, IL-6, nitric oxide (NO), prostaglandin E2 and 
toxic free radicals leading to a condition known 
as neuroinflammation [8]. Neuroinflammation is 
well known to be closely related with the 
pathogenesis of several neurodegenerative 
disorders including Parkinson's and Alzheimer's 
diseases [8,9]. Thus, the control of microglial 
activation has been suggested to be promising 




It is well documented that microglia can be 
activated in vitro by lipopolysaccharide (LPS) 
which enhances the production of immune-
related cytotoxic factors and pro-inflammatory 
cytokines [10] which resembles the in vivo 
conditions in the CNS. Therefore, LPS-activated 
BV-microglia is recognized as an important tool 
for evaluating neuroinflammatory mechanisms 
[11]. In the present investigation, aqueous extract 
of C. carvi was evaluated for its protective effects 
on LPS-activated neuroinflammatory processes 
in BV-2 microglial cells and explored its 




Plant material and preparation of C. carvi 
extract 
 
The dried fruit material of C. carvi procured in the 
month of September 2008 was obtained from 
Chemiloids, Vijayawada, India. The fruit material 
was authenticated by Dr Vidyadar, a Botanist at 
VJ College of Pharmacy and Research Institute, 
Rajahmundry, India and a voucher specimen 
(CCE-VJ/08) was deposited in Pharmacognosy 
Department of VJ College of Pharmacy 
Herbarium, India. The fruit material (1 kg) was 
powdered and extracted with boiling water (5 L) 
for 30 min. The filtrate of C. carvi was evaporated 
under vacuum below 70 °C in a vacuum drier to 
give a final yield of 66.63 g. The C. carvi extract 
(CCE) was dissolved in sterile distilled water, 
filtered on 0.22 µm filters and stored at -20 °C 
until use. All reagents used in this study were of 
highest grade available commercially. 
 
Cell culture and viability assay 
 
Cells were cultured in DMEM supplemented with 
5 % FBS and 100 U/mL P-S in a 37 °C 
humidified incubator with 5 % CO2 and 95 % O2. 
The cells were seeded at a density of 5 × 105 
cells/mL and pretreated for 1 h with various 
concentrations of CCE followed by incubation 
with LPS (1 μg/mL). For viability assay, 3-(4, 5-
dimethylthiazol-2-yl)-2, 5- diphenyl-tetrazolium 
bromide (MTT, Sigma-Aldrich, St. Louis, MO, 
USA) assay was used as described previously 
[12]. The cells were incubated with various 
concentrations of CCE for 24 h followed by MTT 
for 4 h, and then 100 μl of isopropanol (in 0.04 M 
hydrochloric acid) was added to dissolve the 
formazan crystals. The absorbance was read at 
570 nm using the Anthos 2010 
spectrophotometer (Salzburg, Austria). Each 
experiment was conducted in triplicate. 
Percentage of the cell viability was calculated as 
(O.D. of extract treated sample/O.D. of non-
treated sample) x 100 %. 
 
Nitric oxide assay 
 
Production of NO was assayed by measuring the 
levels of nitrite in the culture supernatant using 
colorimetric assay with Griess reagent [13]. BV-2 
cells (2 x 105 cells/mL) were seeded in 6-well 
plates in 500 µL complete culture medium and 
treated with the CCE extract at indicated 
concentrations for 1 h prior to stimulation with 
LPS (1 µg/mL) for 2 h. Culture supernatant (50 
µL) was reacted with an equal volume of Griess 
reagent (0.1 % naphthylethylenediamine and 1 % 
sulfanilamide in (5 % H3PO4) in 96-well plates at 
room temperature in the dark. Nitrite 
concentrations were determined by using 
standard solutions of sodium nitrite prepared in 
the culture medium. The absorbance at 540 nm 
was read using a PowerWavex Microplate 
Scanning spectrophotometer (Bio-Tek 
Instrument, Winooski, VT, USA).  
 
IL-6 and TNF-α production assay 
 
BV-2 microglia cells (1 x 105 cells/well) were 
cultured on 96 well plates and treated with the 
CCE extract at indicated concentrations (25, 50 
and 100 μg/mL) for 1 h  and stimulated with LPS 
(1 µg/mL). At 4 h post-LPS treatment, the cells 
were collected and the supernatants were 
evaluated for TNF-α and IL-6 levels individually, 
using respective murine TNF-α and IL-6 ELISA 
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kits from BD Biosciences (San Jose, CA, USA) 
according to the manufacturer’s instructions. 
 
Nuclear protein extraction and Western blot 
analysis 
 
Cells were washed in cold PBS three times and 
lysed in a buffer containing 50 mM Tris-HCl, pH 
7.4, 1 % (v/v) Tergitol- type NP-40 (NP-40), 0.25 
% sodium deoxycholate, 150 mM NaCl, 1 mM 
EDTA, 25 mM NaF, 2 mM Sodium orthovanadate 
(Na3VO4) and protease inhibitor cocktail 
(Complete MiniTM, Roche, Mannheim, Germany) 
at 4 °C. The lysate was clarified by centrifugation 
at 10,000 g for 20 min at 4 °C to remove 
insoluble components. Cell lysates were 
normalized for protein content using 
bicinchoninic acid reagent (Pierce, Rockford, IL, 
USA). Equal amounts of protein were loaded 
onto 10 % polyacrylamide gel electrophoresis 
(PAGE) and separated by standard sodium 
dodecyl sulphate-PAGE procedure. The proteins 
were transferred to an NC membrane (S&S, 
Dassel, Germany) and blocked with 5 % non-fat 
dry milk in TBS. To detect protein expression, the 
blots were probed with the specific antibodies 
followed by the secondary antibodies coupled to 
horseradish peroxidase (Bio-Rad, Herculus, CA, 
USA) with β-actin as internal control. The 
antibodies against inducible nitric oxide synthase 
(iNOS), cyclooxegenase (COX)-1, COX-2, 
nuclear factor kappa-B (NF-κB), I kappa B-alpha 
(IκB-α) and β-actin were purchased from Cell 
Signaling Technology Inc (Beverly, MA, USA). 
The immunoreactive proteins on the membrane 
were detected by chemiluminescence using the 
West-Save substrate (Lab-Frontier, Seoul, 
Korea) on X-ray film.  
Statistical analysis 
 
All data are presented as mean ± SEM of at least 
three independent experiments. Statistical 
analyses were performed with SAS statistical 
software (SAS Institute, Cray, NC, USA) using 
one-way analysis of variance, followed by 
Dunnett's multiple range tests. P < 0.05 was 




Effect of CCE on BV-2 microglial cell viability  
 
As shown in Fig. 1, CCE treatment for 24 h at 
various concentrations (10-200 µg/mL) did not 
exhibit any significant cytotoxicity on BV-2 
microglial cells. Further, LPS treatment alone (1 
μg/ml) also did not show cytotoxicity to BV-2 
cells. Therefore the non-toxic concentrations of 
CCE (25-200 μg/mL) were further used to 
evaluate the inhibitory properties of CCE in NO 
production in LPS-stimulated BV-2 cells. 
 
Effect of CCE on LPS-induced NO production 
in BV-2 cells 
 
As shown in Fig. 2, cells treated with LPS alone 
(1 μg/mL) significantly increased the NO levels. 
Pretreatment with CCE (25, 50, 100 and 200 
μg/mL) significantly (p < 0.001 at 100 and 200 
μg/mL) and concentration dependently 
suppressed the LPS-stimulated increase in NO 




Figure 1: Effects of CCE on the viability of BV- 2 microglial cells. Viability in CCE treated cells was determined 
using MTT assay. The results are depicted as percentage of control samples. Data are presented as the mean ± 
S.E.M. (n = 3). NS: Not significant; CCE: Carum carvi extract 
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The maximum effect was observed at a 
concentration of 100 μg/mL (p < 0.001). 
Therefore for further experiments we used 25, 50 
and 100 μg/mL concentrations of CCE to obtain 
statistically significant data. 
 
Effect of CCE on LPS-induced expression of 
iNOS and COX levels 
 
CCE (25, 50 and 100 µg/mL) exhibited a marked 
inhibitory effect on the expression of iNOS and 
COX-2 mediators in LPS-stimulated BV-2 cells. 
The LPS-stimulated increase of protein 
expression such as iNOS and inducible COX-2 
were inhibited in a concentration-dependent 
manner. However, constitutive COX-1 protein 
expressional levels were uninterrupted (Fig. 3). 
 
Effect of CCE on IL-6 and TNF-α production in 
LPS-stimulated BV-2 cells  
 
LPS stimulation increased the IL-6 and TNF-α 
level in BV- cells, respectively (p < 0.001). 
However, pretreatment with CCE significantly (p 
< 0.01 and p < 0.001 at 50 and 100 μg/mL) and 
concentration dependently decreased the LPS-
induced IL-6 (Fig. 4A) and TNF-α (Fig. 4B) levels 
in BV-2 microglial cells. 
 
 
Figure 2: Effect of CCE on NO Production in LPS-stimulated BV-2 microglial cells. BV-2 cells were treated with 
CCE at various concentrations (25, 50, 100 and 200 µg/mL) with or without LPS (1µg/ml) for 4 h. The nitrite in the 
culture supernatant was evaluated using Griess reagent. Data are presented as the mean ± S.E.M. (n = 3). #p < 
0.001, when compared with control group. *p < 0.05, **p < 0.01 and ***p < 0.001, when compared with LPS alone 




Figure 3: Effect of CCE on iNOS, COX-1 and COX-2 protein expressional levels in LPS-stimulated BV-2 
microglial cells. The expression levels of iNOS, COX-1 and COX-2 production in the LPS-stimulated BV-2 cells 
by various concentrations (25, 50 and 100 µg/ml) of CCE was monitored by immunoblot analyses with the 
specific antibodies against iNOS, COX-1 and COX-2. The internal control used was β-actin. CCE: Carum carvi 
extract 
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Figure 4: Effect of CCE on pro-inflammatory cytokine IL-6 and TNF-α levels in LPS-stimulated BV-2 cells. BV-2 
cells were treated with CCE at indicated concentrations (25, 50 and 100 µg/mL) with or without LPS (1 µg/mL) for 
4 h. The IL-6 (A) and TNF-α (B) level in the culture supernatant were evaluated using respective murine ELISA 
kits according to the manufacturer’s instruction. Data are presented as the mean ± S.E.M. (n=3).  #p < 0.001, 
when compared with control group. *p < 0.05, **p < 0.01, ***p < 0.001, compared with LPS alone treated group 
by one-way analysis of variance, followed by Dunnett's multiple range tests. CCE: Carum carvi extract 
 
 
Figure 5: Effect of CCE on NF-κB activity in LPS-stimulated BV2 microglia. The expression levels of IκB-α and 
nuclear translocation of p65 NF-κB in the LPS-stimulated BV-2 cells by indicated concentrations (25, 50 and 100 
µg/ml) of the CCE was analyzed by immunoblot analyses with the specific antibodies. The internal control used 
was β-actin. CCE: Carum carvi extract 
 
Effect of CCE on NF-κB levels in LPS-
stimulated BV-2 cells 
 
CCE inhibited the LPS-induced phosphorylation 
and degradation of IκB-α, and nuclear 
translocation of p65 NF-κB in a concentration-
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Mounting evidence suggest that activation of 
microglia is the hallmark of neuroinflammation 
observed in several neurodegenerative diseases 
and pathological conditions of CNS [8,9]. Studies 
have shown that anti-inflammatory agents may 
suppress microglial activation and thus protect 
neuronal cell death observed in various 
neurodegenerative diseases [14,15]. Activated 
microglia can produce several potentially 
neurotoxic substances, including NO, iNOS and 
COX-2.  
 
It is well documented that microglia produces NO 
in response to pro-inflammatory stimuli, and 
iNOS, an important mediator of inflammation 
speeds up the production of NO [16]. NO which 
is a neurotransmitter in the CNS has protective 
functions in anti-inflammatory pathways but at 
high concentrations it produces nitrite free 
radicals therefore being neurotoxic [16]. It was 
reported that COX-2 was markedly up regulated 
in rodent brain microglia and in BV-2 microglial 
cells after LPS treatment [17]. Unlike COX-1, 
COX-2 is normally not present in most cells, but 
its expression is induced in response to 
inflammatory cytokines linked to pathological 
events [18]. In our study, it was observed that 
CCE significantly suppressed nitrite production in 
LPS-stimulated BV-2. Further CCE attenuated 
the increased iNOS and COX-2 expressions 
without altering the COX-1 expression in LPS-
stimulated BV-2 cells. 
 
Pro-inflammatory cytokines such as TNF-α and 
IL-6 cause potent activation of iNOS gene 
expression in rodent glial cells and muscle cells 
[19]. The likelihood of the involvement of CCE in 
attenuating such factors is supported by our 
observations that proinflammatory mediators 
produced by LPS treatment such as TNF-α and 
IL-6 were suppressed by CCE in BV-2 microglial 
cells suggesting that CCE has potent anti-
neuroinflammatory activity through the inhibition 
of NO, iNOS, COX-2 and proinflammatory 
cytokines such as in BV-2 cells TNF-α and IL-6.  
 
NF-κB is an essential and ubiquitous 
transcription factor for the expression of many 
inflammation-related genes, including iNOS, 
COX-2, TNF-α, IL-1β and IL-6. LPS has also 
been reported to activate NF-κB in microglia [20]. 
Here, we confirmed that LPS significantly 
activated NF-κB in BV-2 microglial cells and this 
activation was inhibited by CCE. It is well 
established that the nuclear accumulation of NF-
κB relies in large part upon IκB kinase-dependent 
phosphorylation and subsequent degradation of 
the cytosolic inhibitor, IκB-α. Our result showed 
that CCE inhibited the LPS-induced 
phosphorylation/degradation of IκBα and 
translocation of NF-κB/p65 sub-unit in a 
concentration-dependent manner. Therefore we 
believe that CCE majorly targets in regulating 
NF-κB signaling.  
 
The main constituents of C. carvi are the volatile 
oils including carvone (40–60 %), limonene, 
carveol, terpinene, pinene, linalool, cymene, 
dihydrocarveol and thymol in addition to other 
glycosides and flavonoids [21,22]. C. carvi and 
its active constituents are reported to possess 
strong anti-oxidant properties [3,5,6]. 
Furthermore, carvone which is majorly present in 
C. carvi is known to exhibit anti-inflammatory 
properties by inhibiting the synthesis of 
leukotrienes and prostaglandins [3]. In light of 
such reports, our present data support the notion 
that CCE might play a promising role in exhibiting 
anti-neuroinflammatory properties in LPS-




This study revealed that CCE inhibits 
neuroinflammatory responses in LPS-stimulated 
BV-2 microglial cells via regulation of NF-κB 
signaling and has the potential to be developed 
into a therapeutic agent for the treatment of 
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